NIH-funded research Fellowship grant

How a protein affects immune cells involved in allergies and infections

Official title: Regulation of tissue-resident helper type 2 T cells by fatty acid transport protein 4 (FATP4)

Funded at Johns Hopkins University · NIH-11055383 · Data updated 2026-11-12

This study is looking at how a protein called FATP4 affects certain immune cells that help our body respond to allergies and infections, with the goal of finding new ways to improve immune responses or reduce allergic reactions, especially for people with asthma.

Quick facts

Grant typeFellowship grant
Study typeNIH-funded research
Funding institutionJohns Hopkins University
NIH-funded
Lab location1 site (Baltimore, United States)
Project startApril 1, 2023
Project endMarch 31, 2026
Funding year2025
Award (this year)$76,756
NIH project number5F32AI176630-03
Project IDNIH-11055383 on NIH RePORTER

Who could benefit from this research

Could help

Ideal candidates for this research include individuals suffering from allergic conditions such as asthma or food allergies.

Less likely to help

Patients with non-allergic conditions or those not affected by immune response disorders may not benefit from this research.

What this research studies

This research investigates the role of fatty acid transport protein 4 (FATP4) in regulating a specific type of immune cells known as helper type 2 T cells, which are important in responding to allergens and infections. The study aims to understand how FATP4 influences the metabolism and function of these cells, particularly in the context of allergic responses and conditions like asthma. By examining the mechanisms behind FATP4's action, the research hopes to identify new therapeutic strategies to enhance protective immune responses or mitigate harmful allergic reactions.

Why it matters

Potential benefit: If successful, this research could lead to new treatments for allergic disorders and asthma by targeting the metabolic pathways of immune cells.

How similar studies have gone: Other research has shown promising results in understanding immune cell metabolism, suggesting that this approach could yield significant insights.

Where this research is happening

  • Johns Hopkins University
    Baltimore, United States
    Active

Researchers

  • Principal investigator: Kania, Anna K. — Johns Hopkins University
  • Study coordinator: Kania, Anna K.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.